UNSPSC 85712636: Revision of autologous tissue substitute in left shoulder joint, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in left shoulder joint, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0RWK47Z

UNSPSC 85712636 Revision of autologous tissue substitute in left shoulder joint, percutaneous endoscopic approach is a Commodity code that shows no substantive match between its nominal scope—a surgical procedure on shoulder tissue—and the state and local contract opportunities currently posted under it. The six recent opportunities solicited by state and local agencies span independent medical evaluation services for public safety pension disability determinations, surgical benefit carve-out programs for municipal health plans, occupational medical surveillance for ferry system employees, specialty and emergency medical services for detained youth, pharmacy benefit management administration, and temporary health professional staffing for a county health system. None of these solicitations involve autologous tissue revision, shoulder joint surgery, or percutaneous endoscopic procedures in any medical specialty.

The mismatch suggests either miscoding in the state and local procurement system or a fundamental disconnect between the UNSPSC taxonomy assignment and actual agency purchasing activity. The opportunities originate from diverse issuing bodies—Arizona city retirement boards, California cities, Washington state transportation, Harris County Juvenile Probation, Collier County Commissioners, and Santa Clara County Health System—across Arizona, California, Florida, Texas, and Washington. Without recent opportunities that actually involve the surgical intervention named in the code, there is no actionable business development signal for firms providing autologous tissue substitutes or shoulder joint surgical revision services.